Roles of monocyte chemotactic protein 1 and nuclear factor-κB in immune response to spinal tuberculosis in a New Zealand white rabbit model

This study aimed to explore the roles of monocyte chemotactic protein 1 (MCP-1) and nuclear factor kappa B (NF-kappa B) in immune response to spinal tuberculosis in a New Zealand white rabbit model. Forty-eight New Zealand white rabbits were collected and divided into four groups: experimental group (n= 30, spinal tuberculosis model was established), the sham group (n= 15, sham operation was performed) and the blank group (n= 3). The qRT-PCR assay and western blotting were applied to detect the mRNA and protein expressions of MCP-1 and NF-kappa B in peripheral blood. ELISA was used to measure serum levels of MCP-1, NF-kappa B, IFN-gamma, IL-2, IL-4, and IL-10. Flow cytometry was adopted to assess the distributions of CD4(+), CD8(+) lymphocytes and CD4+ CD25+ Foxp3 lymphocyte subsets. Compared with the sham and blank groups, the mRNA and protein expressions of MCP-1 and NF-kappa B in the experimental group were significantly increased. The experimental group had lower serum levels of IL-2 and IFN-gamma and higher serum level of IL-10 than the sham and blank groups. In comparison to the sham and blank groups, CD4(+) T lymphocyte subsets percentage, CD4(+)/CD8(+) ratio and CD4(+) CD25(+) Foxp3+ Tregs subsets accounting for CD4(+) lymphocyte in the experimental group were lower, while percentage of CD8(+) T lymphocyte subsets was higher. Our study provided evidence that higher expression of MCP-1 and NF-kappa B may be associated with decreased immune function of spinal tuberculosis, which can provide a new treatment direction for spinal tuberculosis.